BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Restoring Cellular Power Outages: A New Drug to Treat Mitochondrial Diseases

  A small biotech company is aiming to recharge tired cells, giving mitochondrial disease patients new hope of a disease-specific treatment.

  August 6, 2020

   · 

  6 min read

   · 

  Chelsea Weidman Burke
• 

  Policy

  With Court Win, BMS and Pfizer Stave Off Eliquis Generic Challengers – For Now

  Eliquis generic was approved by FDA to prevent strokes, blood clots etc. But there were some legal issues which recently got stave off. Know more about it here.

  August 6, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  AstraZeneca Signs First COVID-19 Vaccine Deal with China’s Shenzhen Kangtai

  AstraZeneca signed a deal with Beijing-based Shenzhen Kangtai Biological Products to manufacture AstraZeneca and the University of Oxford’s COVID-19 vaccine in mainland China.

  August 6, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Biopharma Update on the Novel Coronavirus: August 7

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 7, 2020.

  August 6, 2020

   · 

  3 min read

   · 

  BioSpace Editorial Staff
• 

  Drug Development

  Octapharma Uses IVIG as Potential Treatment for COVID-19

  Intravenous immunoglobulin (IVIG) could be a key to combating seriously ill COVID-19 patients who have been hospitalized due to complications from the disease, and Octapharma AG aims to find out as it assesses the plasma-based treatment in a Phase III study.

  August 6, 2020

   · 

  4 min read

   · 

  Alex Keown
• 

  FDA

  FDA Approves GSK’s Blenrep as Fourth-Line Multiple Myeloma Monotherapy Treatment

  Blenrep is GSK’s second regulatory approval in four months. GlaxoSmithKline is once again making its mark as an oncology-focused pharmaceutical company.

  August 6, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Lundbeck Discontinues Phase II Schizophrenia Study Following Interim Analysis

  Denmark-based Lundbeck discontinued a mid-stage proof of concept study of a schizophrenia drug following an interim analysis of data that indicated the study will not achieve statistical significance in its primary endpoint.

  August 6, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Germany’s T-knife Raises $78.4 Million to Develop CAR-T Solid Tumor Therapies

  T-knife GmbH, based in Berlin, Germany, closed a €66 million (about $78.4 million, U.S.) Series A round.

  August 6, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Career Advice

  How to Prepare for the Top 10 Candidate Questions About COVID-19

  As your organization continues with hiring efforts, interviewers will face new questions from candidates that they’ve never been asked before.

  August 6, 2020

   · 

  4 min read

   · 

  Porschia Parker-Griffin
• 

  BioMidwest

  Research Roundup: Possible COVID-19 Treatment and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  August 6, 2020

   · 

  5 min read

   · 

  Mark Terry